Blog
RSS FeedPosted by Michael Wonder on 07 Apr 2026
Update from the PBAC (March 2026)
7 April 2026 - The latest meeting of the PBAC was held 11 – 13 March 2026. ...
Posted by Michael Wonder on 07 Apr 2026
PHARMAC widens access to two melanoma medicines
7 April 2026 - PHARMAC will widen access to two melanoma medicines, giving New Zealanders another funded immunotherapy option and ...
Posted by Michael Wonder on 05 Apr 2026
‘Life-changing’ eczema drug for children caught in $16,000/year PBS limbo
5 April 2026 - A prescription medication for a debilitating skin condition that is listed on the PBS for adults ...
Posted by Michael Wonder on 03 Apr 2026
Butler ‘confident’ of CSL exemption as Australian drugs incur 100pc tariff
3 April 2026 - The Health Minister is hopeful the country’s largest biotech firm CSL will be exempt after Australia was ...
Posted by Michael Wonder on 03 Apr 2026
NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with US
2 April 2026 - New partnership accelerates NHS patients' access to new medicines and will see UK benefit from greater life ...
Posted by Michael Wonder on 03 Apr 2026
Trump slaps 100pc tariffs on Australian drugs – with exceptions
3 April 2026 - Australian drug makers that do not build new factories in America and dramatically cut their prices ...
Posted by Michael Wonder on 03 Apr 2026
Changes to NICE’s cost effectiveness thresholds take effect
2 April 2026 - NICE has implemented new measures to evaluate the cost effectiveness of medicines, following a policy change that ...
Posted by Michael Wonder on 03 Apr 2026
MHRA-NICE pathway opens for business – everything you need to know to get started
1 April 2026 - Today marks a significant milestone for patients, the NHS and the pharmaceutical industry. From 1 April 2026, ...
Posted by Michael Wonder on 02 Apr 2026
Trump puts Australia’s drugs scheme, digital rules in firing line
1 April 2026 - Donald Trump’s top trade tsar claims Australia’s unfair drug pricing practices are undermining US innovation, warns ...
Posted by Michael Wonder on 01 Apr 2026
Injection for more than a million people to help prevent heart attacks and strokes recommended
1 April 2026 - People who have had a heart attack, stroke, or serious circulation problem in their legs, and who ...
Posted by Michael Wonder on 01 Apr 2026
New Zealand Pharmaceutical Schedule - 1 April 2026
1 April 2026 - The April 2026 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Apr 2026
Cheaper medicines for people fighting cancer and rare diseases
1 April 2026 - The Albanese Government is continuing to deliver cheaper medicines with Australians living with debilitating conditions including ...
Posted by Michael Wonder on 31 Mar 2026
Schedule of Pharmaceutical Benefits - 1 April 2026
1 April 2026 - The April 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Mar 2026
Eli Lilly pushes for NHS drug price increases in return for its UK investment
30 March 2026 - US pharmaceutical group ‘optimistic’ about reaching deal with British Government. ...
Posted by Michael Wonder on 30 Mar 2026
Leading cancer drug subsidised for thousands of patients
29 March 2026 - Health Minister Mark Butler has expanded the PBS listing of a leading cancer drug, giving more than ...